Deep Track Capital
Investor profile
Venture capital
Deep Track Capital has backed 4 European tech companies across 4 funding rounds between 2021 and 2025, joining rounds totalling €1.1B. Most active in Healthtech. Data as of Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2021–2025
5 yrs
Total round €
€1.1B
sum of rounds joined
Deals by year
distinct rounds / yearDeep Track Capital — deals by year — interactive chart.
Data table
| Deep Track Capital — deals by year | |
|---|---|
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Top sectors
by dealsDeep Track Capital — top sectors — interactive chart.
Data table
| Deep Track Capital — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsDeep Track Capital — stages — interactive chart.
Data table
| Deep Track Capital — stages | |
|---|---|
| Series C | 2 |
| Other | 1 |
| Series B | 1 |
Countries
by dealsDeep Track Capital — countries — interactive chart.
Data table
| Deep Track Capital — countries | |
|---|---|
| UK | 2 |
| Denmark | 1 |
| Germany | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Invus2
- RA Capital Management2
- Access Biotechnology1
- Andera Partners1
- Ascenta Capital1
- Avidity Partners1
- Avoro Capital Advisors1
- Bayern Kapital1
- CaaS Capital Management1
- EcoR1 Capital1
- EQT Life Sciences1
- Fairmount1
- Forbion1
- Frazier Life Sciences1
- FundPlus1
- HealthCap1
- High-Tech Gründerfonds (HTGF)1
- Maj Invest Equity1
- Nextech Invest1
- Novo Holdings1
- OCCIDENT1
- Omega Funds1
- Perceptive Advisors1
- Piper Heartland Healthcare Capital1
- Rock Springs Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Bicycle Therapeutics | UK | 1 | €512M |
| Tubulis Technologies | Germany | 1 | €308M |
| Artios | UK | 1 | €130M |
| Hemab Therapeutics | Denmark | 1 | €127M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Bicycle Therapeutics | Other | €512M | 2024-05 |
| Tubulis Technologies | Series C | €308M | 2025-10 |
| Artios | Series C | €130M | 2021-07 |
| Hemab Therapeutics | Series B | €127M | 2023-02 |